Search for a research project
Other search option(s)
117 Result(s)
Funded by an IRDiRC member = 
Research projects
GERMANY
Schleswig-Holstein
LÜBECK
Phenotypic spectrum and molecular characterization of Movement disorders
Universität Lübeck
Institut für Neurogenetik
FRANCE
GRAND-EST
ILLKIRCH-GRAFFENSTADEN
PREPARE : Preparing for therapies in autosomal recessive ataxias - FR
Institut de génétique et de biologie moléculaire et cellulaire - IGBMC
Département Médecine translationnelle et neurogénétique
FRANCE
ILE-DE-FRANCE
PARIS
SPATAX-QUEST: Identification of new causative genes in spinocerebellar degenerations by combination of whole genome scan, next-generation sequencing and biological validation in vitro and in vivo
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"
FRANCE
ILE-DE-FRANCE
PARIS
PREPARE : Preparing for therapies in autosomal recessive ataxias - FR
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"
GERMANY
Baden-Württemberg
TÜBINGEN
PREPARE : Preparing for therapies in autosomal recessive ataxias (coordination) - DE
Hertie-Institut für klinische Hirnforschung (HIH)
Abteilung Neurologie mit Schwerpunkt neurodegenerative Erkrankungen
GERMANY
Bayern
MÜNCHEN
New insight in the pathomechanism and therapy of mitochondrial DNA depletion syndrome
Friedrich-Baur-Institut
Labor für Molekulare Myologie
GERMANY
Nordrhein-Westfalen
BONN
PREPARE : Preparing for therapies in autosomal recessive ataxias (coordination) - DE
Projektträger im Deutschen Zentrum für Luft- und Raumfahrt
ERA-Net for research programs on rare diseases - Germany
GERMANY
Sachsen
LEIPZIG
Investigations of molecular mechanisms of mitochondrial biogenesis in vertebrates to gain insight into the relevant pathogenic events in patients presenting with mitochondrial disorders
Biotechnologisch-Biomedizinisches Zentrum der Universität Leipzig
Molekulare Zelltherapie
ITALY
LAZIO
ROMA
SPATAX: European network for hereditary spinocerebellar degenerative disorders
Fondazione EBRI
Istituto di Neurobiologia e Medicina Molecolare
ITALY
VENETO
PADOVA
Deoxynucleotide pool imbalance, mitochondrial DNA maintenance and disease (terminated)
Università degli Studi di Padova- Polo A.Vallisneri
Laboratorio di Biologia Cellulare
PORTUGAL
NORTE
PORTO
SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular
Centro de Genética Preditiva e Preventiva
PORTUGAL
NORTE
PORTO
Clinical implications of genetic factors causing neurodegenerative diseases characterized by movement or cognitive dysfunction.
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas
PORTUGAL
NORTE
PORTO
SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas
PORTUGAL
NORTE
SANTA MARIA DA FEIRA
SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Hospital São Sebastião
Serviço de Neurologia
UNITED KINGDOM
Berkshire
READING
Therapeutic potential of modulators of cannabinoid receptors in cerebellar ataxias
University of Reading
School of Pharmacy
UNITED KINGDOM
Greater London
LONDON
Endogenous Cerebellar Human Stem Cells and their Potential Neuroregenerative Role in Inherited Ataxias
Barts and The London School of Medicine and Dentistry
Centre for Neuroscience and Trauma
UNITED KINGDOM
Greater London
LONDON
Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
Great Ormond Street Hospital for Children, NHS Foundation Trust
Department of Chemical Pathology
UNITED KINGDOM
Greater London
LONDON
Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
National Hospital for Neurology and Neurosurgery
Department of Molecular Neuroscience
UNITED KINGDOM
Greater London
LONDON
Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
UCL Institute of Child Health, University College London
Metabolic Unit
UNITED KINGDOM
Lothian
EDINBURGH
Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
PMARC - The University of Edinburgh
Perception-Movement-Action Research Consortium
UNITED KINGDOM
Lothian
EDINBURGH
Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
School of Informatics, The University of Edinburgh
Human Communication Research Centre
UNITED KINGDOM
Oxfordshire
OXFORD
Development of high throughput genetic testing for cerebellar ataxias
Henry Wellcome Building for Molecular Physiology
BRC Genetics and Pathology Theme
UNITED KINGDOM
Oxfordshire
OXFORD
Development of high throughput genetic testing for cerebellar ataxias
Le Gros Clark Building - University of Oxford
MRC Functional Genetics Unit
UNITED KINGDOM
Oxfordshire
OXFORD
Development of high throughput genetic testing for cerebellar ataxias
The Churchill Hospital
Molecular Genetics Laboratory
UNITED KINGDOM
Oxfordshire
OXFORD
Development of high throughput genetic testing for cerebellar ataxias
The Churchill Hospital
Department of Clinical Genetics
UNITED KINGDOM
Tyne & Wear
NEWCASTLE UPON TYNE
New insight in the pathomechanism and therapy of mitochondrial DNA depletion syndrome
Newcastle upon Tyne Hospitals NHS Trust
Institute of Genetic Medicine
BELGIUM
ANTWERPEN
ANTWERPEN
NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases - BE
University of Antwerp - UA
VIB Department of Molecular Genetics
FRANCE
ILE-DE-FRANCE
PARIS
Neuromics: Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases - FR
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"
GERMANY
Baden-Württemberg
HEIDELBERG
EURENOMICS: European Consortium for High-Throughput Research in Rare Kidney Diseases - DE
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik Kinderheilkunde I - Nephrologisches Labor
GERMANY
Baden-Württemberg
TÜBINGEN
NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Institut für Medizinische Genetik und angewandte Genomik Tübingen
Institut für Medizinische Genetik und angewandte Genomik
GERMANY
Nordrhein-Westfalen
BONN
NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Universitätsklinikum Bonn
Klinik und Poliklinik für Neurologie
GERMANY
Nordrhein-Westfalen
KÖLN
NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Institut für Humangenetik am Universitätsklinikum Köln
Institut für Humangenetik
ITALY
LOMBARDIA
MILANO
NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases - IT
Università degli Studi di Milano - Scienze Farmacologiche e Biomolecolari
Laboratorio di Biologia delle Cellule Staminali
NETHERLANDS
Gelderland
NIJMEGEN
NETHERLANDS
Gelderland
NIJMEGEN
EURENOMICS: European Consortium for High-Throughput Research in Rare Kidney Diseases - NL
Radboudumc - Radboud universitair medisch centrum
Afdeling Fysiologie
NETHERLANDS
Utrecht
UTRECHT
EURENOMICS: European Consortium for High-Throughput Research in Rare Kidney Diseases - NL
UMC Utrecht - Universitair Medisch Centrum Utrecht
Polikliniek Genetica
NETHERLANDS
Zuid-Holland
LEIDEN
NEUROMICS: Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases - NL
LUMC - Leids Universitair Medisch Centrum
Afdeling Humane Genetica
SPAIN
Madrid
MADRID
Muscle atrophy in aging and hereditary neurometabolic pathologies: approach to diagnosis and intervention
Instituto de Investigación Hospital 12 de Octubre
Grupo de investigación en Enfermedades Raras, Mitocondriales y Neuromusculares
SPAIN
Madrid
MADRID
Muscle atrophy in aging and hereditary neurometabolic pathologies: approach to diagnosis and intervention
Instituto de Investigación Hospital 12 de Octubre
Grupo de investigación en Fisiopatología de la Biogénesis Mitocondrial
SPAIN
Madrid
VILLAVICIOSA DE ODÓN
Muscle atrophy in aging and hereditary neurometabolic pathologies: approach to diagnosis and intervention
Universidad Europea de Madrid. Facultad de Ciencias de la Salud
Laboratorio de Fisiología del Ejercicio
UNITED STATES
Arizona
PHOENIX
The etiology of inherited neurological diseases
Phoenix Children's Hospital
Barrow Neurological Institute
CANADA
Alberta
CALGARY
Muscle rehabilitation of cerebral palsy patients recieving botulinum toxin type-A (Botox) treatments
University of Calgary
Faculty of Kinesiology
ITALY
CAMPANIA
NAPOLI
Telethon Undiagnosed Disease Program - Revised Proposal
Azienda Ospedaliera Universitaria - Seconda Università degli Studi di Napoli
Laboratorio di Genetica Medica
ITALY
LAZIO
ROMA
Nuclearly encoded mitochondrial protein synthesis factors can cure the respiratory defects due to pathogenetic human equivalent base substitutions in yeast mt tRNA genes
Sapienza Università di Roma - Dip. di Biologia e Biotecnologie Charles Darwin
Dipartimento di Biologia Cellulare e dello Sviluppo
ITALY
PIEMONTE
TORINO
Functional characterization of missense mutations in SCA28 patients, development of a mouse model of the disease, and screening of candidate genes for cerebellar ataxia
A.O. Città della Salute e della Scienza di Torino - Ospedale Molinette
Genetica Medica
UNITED KINGDOM
Lothian
EDINBURGH
Genetic disorders of human brain development
Western General Hospital
MRC Human Genetics Unit
UNITED KINGDOM
Oxfordshire
OXFORD
Clinical and Genetic Analysis of Ataxias and Related Disorders of Cerebellar Function
The Churchill Hospital
Department of Clinical Genetics
GERMANY
Bayern
MÜNCHEN
RHAPSODY - Research to Assess Policies and Strategies for Dementia in the Young
Klinikum rechts der Isar der Technischen Universität München
Klinik und Poliklinik für Psychiatrie und Psychotherapie
SPAIN
Cataluña
BARCELONA
Genetic-molecular approach of mitochondrial diseases of the OXPHOS system: identification of phenotype conditioning factors
Vall d'Hebron Institut de Recerca VHIR
Unidad de Patología Neuromuscular y Mitocondrial
SPAIN
Madrid
MADRID
Using induced pluripotent stem cells (iPS) for the study and treatment of mitochondrial diseases
Instituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM)
Departamento de Modelos Experimentales de Enfermedades Humanas (Laboratorio de Rafael Garesse Alarcón)
SPAIN
Madrid
MADRID
Mitochondrial diseases: new study strategies, progress in diagnosis and approach to therapy
Instituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM)
Departamento de Modelos Experimentales de Enfermedades Humanas (Laboratorio de Rafael Garesse Alarcón)
SPAIN
Madrid
MADRID
Searching and characterization of biomarkers of mitochondrial diseases associated with enzymatic deficits of the OXPHOS system
Instituto de Investigación Hospital 12 de Octubre
Grupo de investigación en Enfermedades Raras, Mitocondriales y Neuromusculares
AUSTRIA
SALZBURG
SALZBURG
GENOMIT - Mitochondrial Disorders: from a genome-wide Registry to medical genomics, toward molecular mechanisms and new therapies - AT
Salzburger Landeskliniken (SALK) / Paracelsus Med. Privatuniversität (PMU)
Universitätsklinik für Kinder- und Jugendheilkunde
FINLAND
Finland
HELSINKI
Mitochondria, metabolism and disease
Biocenter 1, University of Helsinki
Institute of Biotechnology
FINLAND
Finland
HELSINKI
Molecular basis of mitochondrial disorders
University of Helsinki
Molecular Neurology
FINLAND
Finland
HELSINKI
Mechanisms and consequences of mitochondrial translation defects
University of Helsinki
Molecular Neurology
FINLAND
Finland
HELSINKI
The role of polyamine metabolism and NAD+-dependent enzymes, sirtuins and poly(ADP-ribose) polymerases, in diseases characterized with mitochondrial dysfunction.
University of Helsinki
Molecular Neurology
FINLAND
Finland
TAMPERE
Mitochondria, metabolism and disease
University of Tampere
Institute of Biomedical Technology
FRANCE
ILE-DE-FRANCE
PARIS
GENOMIT : Mitochondrial Disorders: from a genome-wide Registry to medical genomics, toward molecular mechanisms and new therapies - FR
CHU Paris - Hôpital Robert Debré
Equipe "Physiopathologie et thérapie des maladies mitochondriales"
FRANCE
ILE-DE-FRANCE
PARIS
Research on the differential effect of Pioglitazone in mitochondrial diseases
CHU Paris - Hôpital Robert Debré
INSERM U1141- Physiopathologie et thérapie des maladies mitochondriale
FRANCE
ILE-DE-FRANCE
PARIS
GENOMIT : Mitochondrial Disorders: from a genome-wide Registry to medical genomics, toward molecular mechanisms and new therapies - FR
IMAGINE - Institut des Maladies Génétiques
Equipe "Génétique des maladies mitochondriales"
FRANCE
ILE-DE-FRANCE
PARIS
Identification of nuclear genes of mitochondrial diseases with neurological involvement
Laboratoire de Génétique des maladies mitochondriales
UMR_S1163 : Génétique des maladies mitochondriales
FRANCE
NOUVELLE AQUITAINE
BORDEAUX
DEPLETMITO: influence of the amount of mitochondrial DNA on energy metabolism: implications for mitochondrial diseases
Université Bordeaux 2 - Victor Ségalen
Physiopathologie mitochondriale
FRANCE
PROVENCE-ALPES-COTE D'AZUR
NICE
Identification of new genes and possible de novo mutations in early-onset mitochondrial disorders
Faculté de médecine de Nice Sophia-Antipolis
Institut de Recherche sur le Cancer et le Vieillissement
GERMANY
Bayern
MÜNCHEN
GENOMIT- Mitochondrial Disorders: from a pan-European Registry to medical genetics, toward molecular mechanisms and new therapeutic options - DE (coordination)
Helmholtz Zentrum München
Institut für Humangenetik
GERMANY
Bayern
MÜNCHEN
GENOMIT- Mitochondrial Disorders: from a pan-European Registry to medical genetics, toward molecular mechanisms and new therapeutic options - DE (partner no 1)
LMU Klinikum der Universität München - Campus Großhadern
Arbeitsgruppe Neurogenetik
GERMANY
Niedersachsen
GÖTTINGEN
Clinical and genetic presentation of juvenile mitochondriopathies
Universitätsmedizin Göttingen
Klinik für Kinder- und Jugendmedizin
HUNGARY
Közép-Magyarország
BUDAPEST
Investigation of mitochondrial dysfunction with genomic and biochemical analysis
Institute of Genomic Medicine and Rare Disorders, Semmelweis University
Genetics Laboratory
ITALY
LOMBARDIA
MILANO
Identification and characterization of nuclear genes responsible for human mitochondrial disorders
Fondazione IRCCS Istituto Neurologico "C. Besta" - sede Bicocca
U.O. di Neurogenetica Molecolare
ITALY
LOMBARDIA
MILANO
MitMed consortium: from the identification and characterization of nuclear genes responsible for human mitochondrial disorders towards potential therapeutic approaches in experimental models
Fondazione IRCCS Istituto Neurologico "C. Besta" - sede Bicocca
U.O. di Neurogenetica Molecolare
ITALY
TOSCANA
PISA
Developing tools for trial readiness in primary mitochondrial myopathies of the adulthood
Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara
U.O. di Neurologia - Neurofisiopatologia
SPAIN
Madrid
MADRID
Genetic and pharmacogenomic diagnosis of mitochondrial diseases by massive sequencing and functional complementation
Hospital Universitario 12 de Octubre
Unidad Pediátrica de Enfermedades Raras, Enfermedades Mitocondriales y Enfermedades Metabólicas Hereditarias
SPAIN
Madrid
MADRID
Training as modulator inducer of myokines and neurotrophins in mitochondrial diseases: a therapeutic strategy
Instituto de Investigación Hospital 12 de Octubre
Grupo de investigación en Enfermedades Raras, Mitocondriales y Neuromusculares
CANADA
Ontario
OTTAWA
Emerging team in rare diseases: achieving the "triple aim" for inborn errors of metabolism
Children's Hospital of Eastern Ontario
Newborn Screening Ontario
CANADA
Ontario
OTTAWA, ONTARIO
Emerging team in rare diseases: achieving the "triple aim" for inborn errors of metabolism
University of Ottawa
Department of Epidemiology and Community Medicine
FRANCE
HAUTS-DE-FRANCE
LILLE
ID2STOP Orphan : InDividualized Drug Selection Technology for Orphan Patients
Faculté des Sciences Pharmaceutiques et Biologiques de Lille
APTEEUS: le patient au coeur de la découverte de son traitement
ITALY
LIGURIA
GENOVA
New technologies and new strategies for neonatal screening
IRCCS Istituto G. Gaslini - Ospedale Pediatrico
Laboratorio per lo Studio degli Errori Congeniti del Metabolismo
SWEDEN
Stockholms läns landsting
STOCKHOLM
Inborn errors of endocrinology and metabolism
Karolinska Institutet - Solna
Department of Molecular Medicine and Surgery
Multicentric Research projects
- CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
- Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"
- IURC - Institut Universitaire de Recherche Clinique
- Laboratoire de génétique moléculaire
- Hertie-Institut für klinische Hirnforschung (HIH)
- Abteilung Neurologie mit Schwerpunkt neurodegenerative Erkrankungen
- Universitätsklinikum Aachen
- GeNeMove - Netzwerksekretariat
- Fondazione EBRI
- Istituto di Neurobiologia e Medicina Molecolare
- Birmingham Children's Hospital NHS Foundation Trust
- Department of Clinical Inherited Metabolic Disorders
- Institut für Medizinische Genetik und angewandte Genomik Tübingen
- Institut für Medizinische Genetik und angewandte Genomik
- University of British Columbia
- Maternal Infant Child and Youth Research Network
- Institut für Medizinische Genetik und angewandte Genomik Tübingen
- Institut für Medizinische Genetik und angewandte Genomik
- Zentrum für Neuropathologie und Prionforschung (ZNP)
- Zentrum für Neuropathologie und Prionforschung der LMU München
- IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
- Servizio Clinico di Consulenza Genetica
- Hospital Universitari de Bellvitge
- Unidad de Neuropatología
- Universitätsklinikum Bonn
- Kompetenznetz Degenerative Demenzen - Geschäftsstelle
- Radboudumc - Radboud universitair medisch centrum
- Radboud Centrum voor Mitochondriële Geneeskunde
- Camden Mews Day Hospital
- North Thames DeNDRoN, Camden & Islington Mental Health Trust
- Wythenshawe Hospital
- Dementias & Neurodegenerative Diseases Research Network
- Moorgreen Hospital
- Memory & Assessment & Research Centre
- Julian Hospital
- The Churchill Hospital
- Fulbrook Centre
- St Martin's Hospital
- Research Institute for the Care of the Elderly (RICE)
- Newcastle General Hospital
- Wolfson Research Centre
- Université Bordeaux 2 - Victor Ségalen
- Physiopathologie mitochondriale
- CHU d'Angers
- UF de Génétique Moléculaire
- Deutsches MITONET e.V. c/o Dr. Bert Obermaier-Kusser
- Deutsches MITONET e.V.
- Helmholtz Zentrum München
- Institut für Humangenetik
- Helmholtz Zentrum München
- Institut für Humangenetik
- Helmholtz Zentrum München
- Institut für Humangenetik
- LMU Klinikum der Universität München - Campus Großhadern
- Arbeitsgruppe Neurogenetik
- Alzheimer Europe Office
- AZM - Academisch Ziekenhuis Maastricht
- Laboratorium Clinical Genomics
- Instituto de Investigación Hospital 12 de Octubre
- Grupo de investigación en Enfermedades Raras, Mitocondriales y Neuromusculares
- Max-Planck-Institut für experimentelle Medizin
- Abteilung Molekulare Neurobiologie
- University of Ottawa
- Faculty of Medicine -
- CHU de Toulouse - Hôpital Purpan
- Laboratoire de biochimie
- Oxford University Begbroke Science Park
- Zyoxel Limited
- The Sheffield Children's Hospital
- Department of Clinical Chemistry
- The Sheffield Children's Hospital
- Department of Clinical Chemistry
- St James's University Hospital
- Department of Biochemical Genetics
FRANCE
ILE-DE-FRANCE
PARIS
SPATAX: European network for hereditary spinocerebellar degenerative disorders
FRANCE
OCCITANIE
MONTPELLIER
Euro-SCAR: Nosology and molecular diagnosis of the degenerative recessive ataxias
GERMANY
Baden-Württemberg
TÜBINGEN
PREPARE : Preparing for therapies in autosomal recessive ataxias
GERMANY
Nordrhein-Westfalen
AACHEN
GeNeMove: German Network of Hereditary Movement Disorders
ITALY
LAZIO
ROMA
ITASPA: clinical and genetic analysis of spastic paraplegias
UNITED KINGDOM
West Midlands
BIRMINGHAM
Midlands Muscle Network
GERMANY
Baden-Württemberg
TÜBINGEN
Neuromics: Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases
CANADA
Colombie-Britannique
VANCOUVER
Maternal Infant Child and Youth Research Network (MICYRN)
GERMANY
Baden-Württemberg
TÜBINGEN
Ataxia Study Group (ASG)
GERMANY
Bayern
MÜNCHEN
BNE: BrainNet Europe II: European brain tissue bank
ITALY
LAZIO
ROMA
UnRareNet: a muticenter collaborative research network for the identification and study of rare undiagnosed patients (completed)
SPAIN
Cataluña
L'HOSPITALET DE LLOBREGAT
CIEN: Spanish Network for Cooperative Research in Neurological diseases
GERMANY
Nordrhein-Westfalen
BONN
Competence Network Degenerative Dementias
NETHERLANDS
Gelderland
NIJMEGEN
EUMITOCOMBAT: rational treatment strategies combating mitochondrial oxidative phosphorylation (OXPHOS) disorders (TERMINATED)
UNITED KINGDOM
Greater London
LONDON
DENDRON - north Thames region: Dementias & Neurodegenerative Diseases Research Network
UNITED KINGDOM
Greater Manchester
MANCHESTER
DENDRON - north west region: Dementias & Neurodegenerative Diseases Research Network
UNITED KINGDOM
Hampshire
SOUTHAMPTON
DENDRON - south coast region: Dementias & Neurodegenerative Diseases Research Network
UNITED KINGDOM
Norfolk
NORWICH
DENDRON - east Anglia region: Dementias & Neurodegenerative Diseases Research Network
UNITED KINGDOM
Oxfordshire
OXFORD
DENDRON - Thames valley region: Dementias & Neurodegenerative Diseases Research Network
UNITED KINGDOM
Somerset
BATH
DENDRON - south west region: Dementias & Neurodegenerative Diseases Research Network
UNITED KINGDOM
Tyne & Wear
NEWCASTLE UPON TYNE
DENDRON - north east region: Dementias & Neurodegenerative Diseases Research Network
FRANCE
NOUVELLE AQUITAINE
BORDEAUX
MeetOChondrie: research group on mitochondria and related disorders
FRANCE
PAYS DE LA LOIRE
ANGERS
French network on mitochondrial diseases
GERMANY
Bayern
MÜNCHEN
mitoNET: german Network for mitochondrial diseases
GERMANY
Bayern
MÜNCHEN
GENOMIT: Mitochondrial disorders - Connecting Biobanks, Empowering Genetic Diagnostics and Exploring Disease Models
GERMANY
Bayern
MÜNCHEN
GENOMIT: Mitochondrial Disorders: from a genome-wide Registry to medical genomics, toward molecular mechanisms and new therapies
GERMANY
Bayern
MÜNCHEN
GENOMIT- Mitochondrial Disorders: from a pan-European Registry to medical genetics, toward molecular mechanisms and new therapeutic options
GERMANY
Bayern
MÜNCHEN
mitoNET: german Network for mitochondrial diseases
LUXEMBOURG
LUXEMBOURG
LUXEMBOURG
Alzheimer Europe: base de données européenne sur les formes rares de démence
NETHERLANDS
Limburg
MAASTRICHT
MITOCIRCLE: mitochondrial diseases: from bedside to genome to bedside (FINISHED)
SPAIN
Madrid
MADRID
Network for clinical and epidemiological study on mitocondrial respiratory chain diseases in Spain (FINISHED)
GERMANY
Niedersachsen
GÖTTINGEN
EUROSPIN: European consortium on synaptic protein networks in Neurological and Psychiatric diseases
CANADA
Ontario
OTTAWA, ONTARIO
CIMDRN- Canadian Inherited Metabolic Diseases Research Network
FRANCE
OCCITANIE
TOULOUSE
Réseau Sud-Ouest des erreurs innées du métabolisme
UNITED KINGDOM
Oxfordshire
BEGBROKE
TissueGEN: THE PRODUCTION OF A 3D HUMAN TISSUE DISEASE PLATFORM TO ENABLE REGENERATIVE MEDICINE THERAPY DEVELOPMENT
UNITED KINGDOM
South Yorkshire
SHEFFIELD
ERNDIM: European research network for evaluation and improvement of screening-diagnosis-treatment of inherited disorders of metabolism
UNITED KINGDOM
South Yorkshire
SHEFFIELD
MetBioNet - National Metabolic Biochemistry Network
UNITED KINGDOM
West Yorkshire
LEEDS